CO4480761A1 - METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS - Google Patents
METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLSInfo
- Publication number
- CO4480761A1 CO4480761A1 CO96056271A CO96056271A CO4480761A1 CO 4480761 A1 CO4480761 A1 CO 4480761A1 CO 96056271 A CO96056271 A CO 96056271A CO 96056271 A CO96056271 A CO 96056271A CO 4480761 A1 CO4480761 A1 CO 4480761A1
- Authority
- CO
- Colombia
- Prior art keywords
- seq
- chemioquine
- stem cells
- hematopoietic stem
- accordance
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
USO DE UNA PROTEINA DERIVADA DE UNA QUIMIO- QUINA DE MAMIFERO, SELECCIONADA ENTRE EL GRUPO QUE CONSTA DE (a) GRO@SEQ ID NO: 2, (b) groBETA SEQ ID NO: 3, (c) groGAMA SEQ ID NO: 4; Y (d) KC SEQ ID NO: 1, EN LA PREPARACION DE UN MEDICAMENTO UTIL PARA MOVILIZAR CELULAS TRONCO HEMATOPOYETICAS. USO DE ACUERDO CON LA REIVINDICACION 1, EN EL QUE DICHA QUIMIOQUINA SE SELECCIONA DEL GRUPO QUE CONSTA DE: (a) KC MADURA; (b) LOS AMINOACIDOS 5 A 72 DE SEQ ID NO: 1; (c) UNA PROTEINA QUIMIOQUINA MULTIMERICA QUE COM- PRENDE UNA ASOCIACION DE DOS O MAS DE (a) o (b); Y (d) UNA PROTEINA QUIMIOQUINA MULTIMERICA QUE COM- PRENDE UNA ASOCIACION DE (a) o (b) CON UNA SEGUNDA QUIMIOQUINA. USO DE ACUERDO CON LAS REIVINDICACIONES 1-5, EN EL QUE DICHO MEDICAMENTO SE ADMINISTRA CONJUN- TAMENTE CON UN FACTOR DE CRECIMIENTO U OTRA BIOMO- LECULA REGULADORA HEMATOPOYETICA. 1 USO DE ACUERDO CON LA REIVINDICACION 10, EN EL QUE EL PACIENTE HA RECIBIDO UNA DOSIS DE UN A- GENTE QUIMIOTERAPEUTICO SELECCIONADO, ANTES DEL TRATAMIENTO CON EL MEDICAMENTO; SE RECOGEN LAS CELULAS TRONCO HEMATOPOYETICAS PROCEDENTES DE LA SANGRE PERIFERICA DEL PACIENTE TRATADO; SE ADMI- NISTRA UN AGENTE QUIMIOTERAPEUTICO; Y SE VUELVE A INFUNDIR EL PACIENTE CON LAS CELULAS RECOGIDAS.USE OF A PROTEIN DERIVED FROM A MAMMALIAN CHEMIOQUINE, SELECTED FROM THE GROUP CONSISTING OF (a) GRO @ SEQ ID NO: 3, (b) groBETA SEQ ID NO: 3, (c) groGAMA SEQ ID NO: 4 ; AND (d) KC SEQ ID NO: 1, IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT TO MOBILIZE HEMATOPOIETIC STEM CELLS. USE IN ACCORDANCE WITH CLAIM 1, IN WHICH SUCH CHEMIOQUINE IS SELECTED FROM THE GROUP WHICH CONSISTS OF: (a) KC MATURA; (b) AMINO ACIDS 5 TO 72 OF SEQ ID NO: 1; (c) A MULTIMERICAL CHEMIOKINE PROTEIN COMPRISING AN ASSOCIATION OF TWO OR MORE THAN (a) or (b); AND (d) A MULTIMERICAL CHEMIOQUINE PROTEIN COMPOSING AN ASSOCIATION OF (a) or (b) WITH A SECOND CHEMIOQUINE. USE IN ACCORDANCE WITH CLAIMS 1-5, IN WHICH SUCH MEDICATION IS ADMINISTERED TOGETHER WITH A GROWTH FACTOR OR ANOTHER HEMATOPOYETIC REGULATORY BIOMOLECULA. 1 USE IN ACCORDANCE WITH CLAIM 10, IN WHICH THE PATIENT HAS RECEIVED A DOSE OF A SELECTED CHEMOTHERAPEUTICAL AGENT, BEFORE TREATMENT WITH THE MEDICINAL PRODUCT; THE HEMATOPOIETIC STEM CELLS FROM THE PERIPHERAL BLOOD OF THE TREATED PATIENT ARE COLLECTED; A CHEMOTHERAPEUTICAL AGENT IS ADMITTED; AND THE PATIENT IS INFUSED AGAIN WITH THE COLLECTED CELLS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO96056271A CO4480761A1 (en) | 1996-10-24 | 1996-10-24 | METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO96056271A CO4480761A1 (en) | 1996-10-24 | 1996-10-24 | METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4480761A1 true CO4480761A1 (en) | 1997-07-09 |
Family
ID=40929744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96056271A CO4480761A1 (en) | 1996-10-24 | 1996-10-24 | METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO4480761A1 (en) |
-
1996
- 1996-10-24 CO CO96056271A patent/CO4480761A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2186693T3 (en) | COMBINED USE OF HIALURONIC ACID AND THERAPEUTIC AGENTS TO IMPROVE THE THERAPEUTIC EFFECT. | |
SE9302308L (en) | protein Preparation | |
SE8504945L (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTRACYCLING GYCOSIDES | |
BG60253B1 (en) | HUMAN TISSUE PLASMINOGENIC ACTIVATOR | |
DE3680368D1 (en) | BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIE FACTOR, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS. | |
ATE62414T1 (en) | AGENT FOR THE TREATMENT OF HEART DISEASES. | |
IS3284A7 (en) | Process for the preparation of N1-substituted benzimidazole derivatives for therapeutic use | |
DK0934424T3 (en) | Process for Preparation of a Recombinant Polypeptide, Adding an Inhibitor of Metal-Dependent Proteases or Chymotrypsins to the Cell Culture Medium | |
ATE277628T1 (en) | TREATMENT OF HEMATOPOIETIC CELLS WITH CXCR4 AGONISTS | |
HUP9602498A2 (en) | Pharmaceutical compositions of antimicrobial activity | |
RU94046426A (en) | Pharmaceutical compositions, methods of leukosis treatment, method of stem cell level increase, antagonist c-kit-ligand, nonsense nucleic acid, method of melanoma treatment, method of transfection enhancement, method of gene transfer, method of peripheral blood level increase, method of platelet level increase, method of biological function modification, method of anemia treatment, method of bone marrow implantation improvement, method of bone marrow recovery acceleration, method of leukopenia treatment | |
DE58901002D1 (en) | AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES. | |
AR002027A1 (en) | TRANSDERMIC FORMULATIONS AND PROCESS TO PREPARE THEM. | |
FI801228A (en) | 6-SUBSTITUTES OF 11-ALKYLENE-MORPHANTRIDINES | |
ATE132187T1 (en) | BAT SALIVA PLASMINOGEN ACTIVator VPA-ALPHA 1 | |
ES2107414T3 (en) | USE OF HUMAN INTERFERON-BETA FOR THE STIMULATION OF ERYTHROPOYESIS. | |
NO810480L (en) | ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES | |
CO4480761A1 (en) | METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS | |
ES2042529T3 (en) | A PROCEDURE FOR PREPARING A COMBINED THERAPEUTIC COMPOSITION OF A FREE RADICALS REMOVAL OR METABOLIC INHIBITOR AND A BIOLOGICALLY ACTIVE PROTEIN. | |
GB1537047A (en) | Eye ointment | |
HUP9903679A2 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder | |
ATE2746T1 (en) | PIPERIDINE DERIVATIVES OF 4,5-DIALKYL-3-HYDROXYPYRROL-2-CARBONS[UREESTERS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
ATE12649T1 (en) | OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
ES8303403A1 (en) | 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5 diols, process for their preparation, pharmaceutical preparations containing them and their therapeutical use. | |
ES2165366T3 (en) | PROCEDURES AND COMPOSITIONS TO INHIBIT THE INFLAMMATION MEDIATED BY ENDOTELIAL CELLS AND FIBRINOGEN. |